investing

Biggest Blockbuster Drugs of All Time

Lipitor, Humira and Advair boosted the bottom lines of Big Pharma companies and their shareholders for years.

A prescription drug that surpasses $1 billion in sales is known as a blockbuster. It's a rare feat, but when a pharmaceutical company finds a true blockbuster drug the payoff is enormous. How enormous? Check out the three best-selling prescription drugs of all time.

Blockbuster Drug #1: Lipitor

Company: Pfizer (PFE)

Treats: High cholesterol

Lifetime sales: $150.1 billion

Originally developed by Warner-Lambert, Lipitor was approved in the U.S. in 1997. Pfizer acquired its rival in 2000 to gain sole ownership of the cholesterol-fighting drug – and it was well worth it. At one point, Lipitor accounted for one-fourth of Pfizer’s sales. The patent expired in 2011.

Blockbuster Drug #2: Humira

Company: AbbVie (ABBV)

Treats: Ankylosing spondylitis, arthritis, Crohn’s disease, plaque psoriasis, ulcerative colitis

Lifetime sales: $109.2 billion

Doctors praise Humira’s ability to combat damaging inflammation caused by a number of diseases. Sales will likely peak in 2018 as the drug begins to lose patent protection, but it’s been a heck of a run. Humira is owned by AbbVie, an industry giant that was spun off from Abbott Labs in 2013.

Blockbuster Drug #3: Advair

Company: GlaxoSmithKline (GSK)

Treats: Chronic obstructive pulmonary disease, asthma

Lifetime sales: $95.7 billion

Advair has been a huge seller since its approval in 2001. And even though its U.S. patent expired in 2010, no successful generic competitor has surfaced. Copying the drug isn’t the problem. Rather, rivals have yet to figure out how to copy the inhaler. Until they do, Glaxo investors can breathe easy.

Most Popular

Your Guide to Roth Conversions
Special Report
Tax Breaks

Your Guide to Roth Conversions

A Kiplinger Special Report
February 25, 2021
The 25 Cheapest U.S. Cities to Live In
places to live

The 25 Cheapest U.S. Cities to Live In

Take a look at our list of American cities with the lowest costs of living. Is one of the cheapest cities in the U.S. right for you?
October 13, 2021
4 Big Retirement Blunders (and How to Avoid Them)
retirement

4 Big Retirement Blunders (and How to Avoid Them)

It’s too bad, but financial advisers see these four mistakes all the time. Don’t fall into the same traps.
October 6, 2021

Recommended

Billed for a COVID-19 Vaccine? Don't Pay
Healthy Living on a Budget

Billed for a COVID-19 Vaccine? Don't Pay

If you are charged, it's an error. Call your provider directly and dispute the fees.
October 25, 2021
11 Costly Medicare Mistakes You Should Avoid Making
Medicare

11 Costly Medicare Mistakes You Should Avoid Making

If you don't make the right choices, you could end up with high Medicare premiums and big out-of-pocket costs.
October 20, 2021
The Pros and Cons of Target Date Funds with Tony Drake
Financial Planning

The Pros and Cons of Target Date Funds with Tony Drake

The simplicity of target date funds has made them popular, particularly among 401(k) savers. But investors may be paying a price.
October 19, 2021
Robo-Advisers: Weighing the Worth of Automated Advice
investing

Robo-Advisers: Weighing the Worth of Automated Advice

Some people do just fine with bare-bones advice that’s essentially generated by an algorithm. Until your financial life gets more complicated, you mig…
October 17, 2021